NEW YORK (GenomeWeb News) – Decode Genetics said last night that it has received a letter from the Nasdaq that effectively stays delisting of the firm's stock from the Nasdaq Capital Market, which could have occurred tomorrow.

The Nasdaq Listing and Hearing Review Council called for a review of an April 22 determination of the Nasdaq Listing Qualifications Panel that it would have delisted Decode's shares on April 30.